| 11/05/2026 5:30 PM | Gyre Therapeutics (1124105) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2026 3:30 PM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2026 3:01 PM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/01/2026 8:00 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 8:00 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2026 4:00 PM | Gyre Therapeutics (1124105) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/07/2026 7:00 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/04/2026 7:39 PM | Gyre Therapeutics (1124105) Issuer Kirkby Maxwell (2060862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 7:45 PM | Gyre Therapeutics (1124105) Issuer Weston Claire (2060874) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 7:24 PM | Gyre Therapeutics (1124105) Issuer Kirkby Maxwell (2060862) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/04/2026 7:31 PM | Gyre Therapeutics (1124105) Issuer Weston Claire (2060874) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for GYRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/03/2026 11:15 PM | Gyre Therapeutics (1124105) Filer | Form EFFECT | |
| 07/16/2026 3:35 PM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 4:09 PM | Gyre Therapeutics (1124105) Filer | Form 8-K/A | |
| 07/13/2026 4:00 PM | Gyre Therapeutics (1124105) Filer | Form S-3/A | |
| 06/30/2026 5:17 PM | Gyre Therapeutics (1124105) Issuer Nussbaum Rodney L (2014225) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 5:17 PM | Gyre Therapeutics (1124105) Issuer Zhang Ping (2050176) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 5:17 PM | Gyre Therapeutics (1124105) Issuer Parry Renate (1982817) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 5:17 PM | Gyre Therapeutics (1124105) Issuer Weng Dan (2083482) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 5:17 PM | Epstein David M. (1488668) Reporting Gyre Therapeutics (1124105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 5:17 PM | Carmichael Gordon (1982077) Reporting Gyre Therapeutics (1124105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:02 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 5:30 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 3:01 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 3:01 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:13 PM | Gyre Therapeutics (1124105) Issuer Luo Ying (1959160) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:13 PM | Bergmann Joshua Benjamin (2131863) Reporting Gyre Therapeutics (1124105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2026 8:55 PM | Gyre Therapeutics (1124105) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/08/2026 3:01 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 5:09 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/22/2026 5:19 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 8:03 PM | Gyre Therapeutics (1124105) Issuer Zhang Ping (2050176) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 3:01 PM | Gyre Therapeutics (1124105) Issuer Ye Weiguo (1985496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 4:25 PM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 4:03 PM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/11/2026 6:10 AM | Gyre Therapeutics (1124105) Subject Ye Weiguo (1985496) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/08/2026 3:16 PM | Gyre Therapeutics (1124105) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 8:58 PM | Gyre Therapeutics (1124105) Issuer Luo Ying (1959160) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 8:23 PM | Gyre Therapeutics (1124105) Issuer Luo Ying (1959160) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:23 PM | Gyre Therapeutics (1124105) Issuer Xiong Yue (2061391) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:23 PM | Gyre Therapeutics (1124105) Issuer Wang Jialiang (0) NMN | Form 3 Initial statement of beneficial ownership of securities | |
Your free book is about to disappear (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 05/07/2026 8:23 PM | Bergmann Joshua Benjamin (2131863) Reporting Gyre Therapeutics (1124105) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 5:01 AM | Gyre Therapeutics (1124105) Subject Ma Songjiang (1985547) Filed by | Form SCHEDULE 13D/A | |
| 05/06/2026 8:53 PM | Gyre Therapeutics (1124105) Subject Luo Ying (1959160) Filed by | Form SCHEDULE 13D/A | |
| 05/06/2026 7:38 PM | Eastling Thomas Wilson (1958487) Reporting Gyre Therapeutics (1124105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 7:40 PM | GNI Group Ltd. (1958461) Reporting GNI USA, Inc. (1973229) Reporting Gyre Therapeutics (1124105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 7:46 PM | GNI Group Ltd. (1958461) Filed by Gyre Therapeutics (1124105) Subject | Form SCHEDULE 13D/A | |
| 05/04/2026 8:12 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 8:13 AM | Gyre Therapeutics (1124105) Filer | Form DEFA14A | |
| 04/27/2026 3:30 PM | Gyre Therapeutics (1124105) Filer | Form DEF 14A | |
| 04/27/2026 3:31 PM | Gyre Therapeutics (1124105) Filer | Form DEFA14A | |
| 04/27/2026 3:31 PM | Gyre Therapeutics (1124105) Filer | Form ARS | |
| 04/17/2026 7:55 AM | Gyre Therapeutics (1124105) Filer | Form 8-K/A | |
| 04/16/2026 3:13 PM | Gyre Therapeutics (1124105) Filer | Form PRE 14A | |
| 03/23/2026 6:51 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 3:31 PM | Gyre Therapeutics (1124105) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 5:31 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 8:24 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 6:06 AM | Gyre Therapeutics (1124105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |